These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 198953)

  • 21. [Effect of Production on the serum lipid and lipoprotein level in ischemic heart disease].
    Orbetsov M; Orbetsova V; Todorova M; Mikhaĭlova M; Atanasova M
    Vutr Boles; 1977; 16(6):16-22. PubMed ID: 203118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins.
    Richter WO; Jacob BG; Schwandt P
    Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum and tissue levels of six trace elements and copper/zinc ratio in patients with cervical cancer and uterine myoma.
    Cunzhi H; Jiexian J; Xianwen Z; Jingang G; Shumin Z; Lili D
    Biol Trace Elem Res; 2003 Aug; 94(2):113-22. PubMed ID: 12958402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.
    Kimak E; Ksiazek A; Baranowicz-Gaszczyk I; Solski J
    Ren Fail; 2007; 29(6):705-12. PubMed ID: 17763166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
    Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L
    Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The 8th annual report of the Comittee on Uterine Cancer. Therapeutic results in cervical cancer of 5-7 years' duration treated from 1953-60 and the results in uterine cancer of 5 years' duration].
    Nihon Sanka Fujinka Gakkai Zasshi; 1967 Mar; 19(3):293-346. PubMed ID: 6070782
    [No Abstract]   [Full Text] [Related]  

  • 28. [Strontium content of the plasma and formed elements of the blood in uterine neoplasms and changes in its content with different types of treatment].
    Rybnikov VI
    Akush Ginekol (Mosk); 1968 Aug; 44(8):27-31. PubMed ID: 5760928
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of the B-protein assay in cancer management.
    McGehee RP; Bucovaz ET; Whybrew WD; Griffis KR; Cothern D; Schweikert A; Morrison JC
    Am J Obstet Gynecol; 1988 Apr; 158(4):960-3. PubMed ID: 3364505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The 25th annual report of the Uterine Cancer Registry Committee. Results of the treatment of uterine cancer during 1968-1977].
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1977-2045. PubMed ID: 6501975
    [No Abstract]   [Full Text] [Related]  

  • 31. alpha-Fetoprotein as a biochemical marker in patients with gynecologic malignancy.
    Donaldson ES; van Nagell JR; Gay EC; Purcell S; Meeker WR; Kashmiri R; Hunter L; van de Voorde J
    Gynecol Oncol; 1979 Feb; 7(1):18-24. PubMed ID: 86481
    [No Abstract]   [Full Text] [Related]  

  • 32. Low serum selenium concentration in patients with cervical or endometrial cancer.
    Sundström H; Yrjänheikki E; Kauppila A
    Int J Gynaecol Obstet; 1984 Feb; 22(1):35-40. PubMed ID: 6144589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum lipids in human cancer.
    Mays ET
    J Surg Res; 1969 May; 9(5):273-7. PubMed ID: 5813710
    [No Abstract]   [Full Text] [Related]  

  • 34. [Metastasic osseus series in the determination of the clinical stage of cervicouterine cancer].
    Mirabent González F; Fernández Alba J; Díaz FA; Marbez Namnum E
    Ginecol Obstet Mex; 1980 Apr; 47(282):269-73. PubMed ID: 7390221
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum lipid profile and its relationship with host immunity in carcinomas of the breast and uterine cervix.
    Ray A; Sharma BK; Bahadur AK; Pasha ST; Bhadola P; Murthy NS
    Tumori; 1997; 83(6):943-7. PubMed ID: 9526589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Behavior of C-reactive protein (CRP) in various evolutive stages of carcinoma of the cervix and of the uterine body after surgery and in patients of former, clinically cured neoplasms].
    CUTRERA A
    Riv Ostet Ginecol; 1961 Jun; 16():392-7. PubMed ID: 13882824
    [No Abstract]   [Full Text] [Related]  

  • 37. [The effect of the serum of patients with malignant neoplasms on the multiplication of cells in tissue culture].
    Kiselev PN; L'vovskiĭ EA; Gabelov AA; Kuz'mina VA; Golubev DB
    Akush Ginekol (Mosk); 1971 Sep; 47(9):46-9. PubMed ID: 5154956
    [No Abstract]   [Full Text] [Related]  

  • 38. [The state of blood coagulation in patients with cancer of the uterus according to thrombelastographic findings].
    Pafalovich MB; Zil'bert NI
    Akush Ginekol (Mosk); 1972 Oct; 48(10):65-6. PubMed ID: 4664989
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum lipids in uterine cancer].
    Némèth D; Skarupinski N; Bánné K
    Vopr Onkol; 1977; 23(7):22-6. PubMed ID: 198953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristics of dyslipidemia in cancer patients].
    Ostroumova MN; Kovalenko IG; Bershteĭn LM; Tsyrlina EV; Dil'man VM
    Vopr Onkol; 1986; 32(1):34-43. PubMed ID: 3946086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.